SEC Company Response from Cabaletta Bio, Inc. (CABA) (CIK 0001759138) (CABA) — Oct 22, 2019
Cabaletta Bio, Inc. (CABA) (CIK 0001759138)
Date: Oct. 22, 2019 · CIK: 0001759138 · Accession: 0001193125-19-271633
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-234017
Letter
Re: Cabaletta Bio, Inc.
October 22, 2019
VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance
Mail Stop 4561
100 F Street, N.E.
Washington, D.C. 20549
Registration Statement on Form S-1 (File No. 333-234017) (the “Registration Statement”)
Ladies and Gentleman:
In connection with the above-referenced Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we hereby join in the request of Cabaletta Bio, Inc. that the effective date of the Registration Statement be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on October 24, 2019, or as soon thereafter as practicable.
Pursuant to Rule 460 under the Act, please be advised that we and the other prospective underwriters have distributed approximately 2,080 copies of the preliminary prospectus dated October 16, 2019 (the “Preliminary Prospectus”) through the date hereof to underwriters, dealers, institutions and others.
In connection with the Preliminary Prospectus distribution for the above-referenced issue, we hereby confirm that we are, and the other prospective underwriters have confirmed that they are, complying with the 48-hour requirement as promulgated by Rule 15c2-8 under the Securities Exchange Act of 1934, as amended.
[Remainder of page intentionally left blank]
Very truly yours,
MORGAN STANLEY & CO. LLC
Show Raw Text
CORRESP 1 filename1.htm CORRESP October 22, 2019 VIA EDGAR United States Securities and Exchange Commission Division of Corporation Finance Mail Stop 4561 100 F Street, N.E. Washington, D.C. 20549 Re: Cabaletta Bio, Inc. Registration Statement on Form S-1 (File No. 333-234017) (the “Registration Statement”) Ladies and Gentleman: In connection with the above-referenced Registration Statement, and pursuant to Rule 461 under the Securities Act of 1933, as amended (the “Act”), we hereby join in the request of Cabaletta Bio, Inc. that the effective date of the Registration Statement be accelerated so that it will be declared effective at 4:00 p.m. Eastern Time on October 24, 2019, or as soon thereafter as practicable. Pursuant to Rule 460 under the Act, please be advised that we and the other prospective underwriters have distributed approximately 2,080 copies of the preliminary prospectus dated October 16, 2019 (the “Preliminary Prospectus”) through the date hereof to underwriters, dealers, institutions and others. In connection with the Preliminary Prospectus distribution for the above-referenced issue, we hereby confirm that we are, and the other prospective underwriters have confirmed that they are, complying with the 48-hour requirement as promulgated by Rule 15c2-8 under the Securities Exchange Act of 1934, as amended. [Remainder of page intentionally left blank] Very truly yours, MORGAN STANLEY & CO. LLC COWEN AND COMPANY, LLC EVERCORE GROUP, L.L.C. As Representatives of the several Underwriters MORGAN STANLEY & CO. LLC. By: /s/ Kalli Dircks Name: Kalli Dircks Title: Executive Director COWEN AND COMPANY LLC By: /s/ Bill Follis Name: Bill Follis Title: Managing Director EVERCORE GROUP, L.L.C. By: /s/ Maren Winnick Name: Maren Winnick Title: Senior Managing Director [Signature Page to Request for Acceleration of Effectiveness]